Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-GenzymeLu Wang, Cheng Zhang, Ting Chen et al.|Annals of Hematology|2023Cited by 11
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical TrialYimei Feng, Xi Zhang, Hai Yi et al.|American Journal of Hematology|2025Cited by 5
Thrombopoietin receptor agonists for refractory thrombocytopenia in patients after autologous hematopoietic stem cell transplantationDan Wang, Yimei Feng, Zhongmin Zou et al.|Transplant Immunology|2023Cited by 4
Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring systemMingyang Gao, Shichun Gao, Jianchuan Deng et al.|Annals of Hematology|2024Cited by 1
P1325: EFFICACY AND SAFETY OF HEROMBOPAG FOR THE TREATMENT OF SECONDARY FAILURE OF PLATELET RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONLu Wang, Xi Zhang, Jia Liu et al.|HemaSphere|2023Cited by 0